Phase II. Randomized, Double-Blind Study to Assess the E

Project: Research project

Project Details

Description

Phase II. Randomized, Double-Blind Study to Assess the Efficacy and Safety of Lebrikzumab in Patients with Idiopathic Pulmonary Fibrosis
StatusFinished
Effective start/end date6/25/1412/31/17

Funding

  • Genentech Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.